The White House’s decision to invoke Section 122 of the Trade Act of 1974 for a temporary 10-15% duty is being viewed by Indian analysts as a sign of a larger protectionist agenda. This across-the-board hike could potentially squeeze the margins of Indian exporters in price-sensitive segments like engineering and electronics. However, the exclusion of pharmaceuticals and essential goods offers a strategic cushion for India’s large-scale manufacturing sectors. Experts suggest that if these US actions hit competing nations harder, India could seize the opportunity to rebrand itself as a stable and trustworthy supplier. The situation encourages India to fast-track its “Make in India” initiative and attract companies looking for alternative global manufacturing hubs.